• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1999-2015 年韩国宫颈癌、子宫内膜癌和卵巢癌的发病率。

Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.

机构信息

Cancer Healthcare Research Branch, Center for Uterine Cancer, and Center for Clinical Trials, National Cancer Center, Goyang, Korea.

Cancer Registration and Statistics Branch, National Cancer Center, Goyang, Korea.

出版信息

J Gynecol Oncol. 2019 Jan;30(1):e38. doi: 10.3802/jgo.2019.30.e38.

DOI:10.3802/jgo.2019.30.e38
PMID:30574686
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6304410/
Abstract

OBJECTIVE

To investigate the incidence and trends of cervical (C53), endometrial (C54.1), and ovarian cancer (C56) among Korean females between 1999 and 2015.

METHODS

The incidence of the three major gynecological cancers between 1999 and 2015 was analyzed based on the data from the Korea Central Cancer Registry. The age-standardized rates (ASRs) and the annual percent changes (APCs) for each site were calculated.

RESULTS

The absolute incidence rates of the three major gynecological cancers increased from 6,394 in 1999 to 8,288 in 2015. ASR for gynecologic cancer decreased from 23.7 per 100,000 in 1999 to 21.1 in 2015. This was mainly due to a definitive decrease in the incidence of cervical cancer, which recorded an APC of -3.7%. The trends of APC for gynecologic cancer were variable, being -1.36% between 1999 and 2006 and -0.11% between 2006 and 2015. A definitive but variable increase was noted for endometrial cancer, and the APC for this cancer was 7.4% between 1999 and 2009 and 3.5% between 2009 and 2015. The incidence of ovarian cancer gradually increased, with an APC of 1.8% between 1999 and 2015.

CONCLUSION

Overall, ASRs and APCs for the three major gynecological cancers are decreasing, with a recent reduction in the width of the change. However, there has been a progressive increase in the incidence of endometrial and ovarian cancers.

摘要

目的

调查 1999 年至 2015 年期间韩国女性中宫颈(C53)、子宫内膜(C54.1)和卵巢癌(C56)的发病率和趋势。

方法

基于韩国中央癌症登记处的数据,分析了 1999 年至 2015 年期间三种主要妇科癌症的发病率。计算了每个部位的年龄标准化率(ASR)和年百分比变化(APC)。

结果

三种主要妇科癌症的绝对发病率从 1999 年的 6394 例上升至 2015 年的 8288 例。妇科癌症的 ASR 从 1999 年的每 100,000 人 23.7 例下降至 2015 年的 21.1 例。这主要是由于宫颈癌发病率的明确下降,其 APC 为-3.7%。妇科癌症的趋势各不相同,1999 年至 2006 年为-1.36%,2006 年至 2015 年为-0.11%。子宫内膜癌则呈现明确但可变的上升趋势,1999 年至 2009 年的 APC 为 7.4%,2009 年至 2015 年为 3.5%。卵巢癌的发病率逐渐上升,1999 年至 2015 年的 APC 为 1.8%。

结论

总体而言,三种主要妇科癌症的 ASR 和 APC 呈下降趋势,变化幅度近期有所缩小。然而,子宫内膜癌和卵巢癌的发病率呈逐渐上升趋势。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/6304410/64ae3088aa33/jgo-30-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/6304410/01ac0641a417/jgo-30-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/6304410/64ae3088aa33/jgo-30-e38-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/6304410/01ac0641a417/jgo-30-e38-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/71a1/6304410/64ae3088aa33/jgo-30-e38-g002.jpg

相似文献

1
Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.1999-2015 年韩国宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2019 Jan;30(1):e38. doi: 10.3802/jgo.2019.30.e38.
2
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.韩国 1999-2010 年宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2013 Oct;24(4):298-302. doi: 10.3802/jgo.2013.24.4.298. Epub 2013 Oct 2.
3
Ethnicity-related trends in gynecologic malignancies in Israel, 1993-2013.1993-2013 年以色列妇科恶性肿瘤与种族相关的趋势。
Int J Gynaecol Obstet. 2018 Aug;142(2):176-181. doi: 10.1002/ijgo.12524. Epub 2018 May 30.
4
Incidence of Cervical, Ovarian and Uterine Cancer in Eritrea: Data from the National Health Laboratory, 2011-2017.厄立特里亚宫颈癌、卵巢癌和子宫癌的发病率:来自 2011-2017 年国家卫生实验室的数据。
Sci Rep. 2020 Jun 4;10(1):9099. doi: 10.1038/s41598-020-66096-5.
5
Temporal Changes in Incidence Rates of the Most Common Gynecological Cancers in the Female Population in Central Serbia.塞尔维亚中部女性人群中最常见妇科癌症发病率的时间变化。
Medicina (Kaunas). 2022 Feb 17;58(2):306. doi: 10.3390/medicina58020306.
6
Incidence of epithelial ovarian cancer according to histologic subtypes in Korea, 1999 to 2012.1999年至2012年韩国上皮性卵巢癌按组织学亚型划分的发病率
J Gynecol Oncol. 2016 Jan;27(1):e5. doi: 10.3802/jgo.2016.27.e5. Epub 2015 Dec 1.
7
Clinical statistics of gynecologic cancers in Japan.日本妇科癌症的临床统计数据。
J Gynecol Oncol. 2017 Mar;28(2):e32. doi: 10.3802/jgo.2017.28.e32. Epub 2017 Feb 10.
8
Comparison of crude and age-specific incidence rates of breast, ovary, endometrium and cervix cancers in Iran, 2005.2005年伊朗乳腺癌、卵巢癌、子宫内膜癌和宫颈癌粗发病率与年龄别发病率比较
Asian Pac J Cancer Prev. 2014;15(6):2461-4. doi: 10.7314/apjcp.2014.15.6.2461.
9
Trends in the incidence of in situ and invasive cervical cancer by age group and histological type in Korea from 1993 to 2009.韩国 1993 年至 2009 年按年龄组和组织学类型划分的原位和浸润性宫颈癌发病率趋势。
PLoS One. 2013 Aug 16;8(8):e72012. doi: 10.1371/journal.pone.0072012. eCollection 2013.
10
Temporal Trends of Common Female Malignances on Breast, Cervical, and Ovarian Cancer Mortality in Japan, Republic of Korea, and Singapore: Application of the Age-Period-Cohort Model.日本、韩国和新加坡女性乳腺癌、宫颈癌和卵巢癌死亡率的常见女性恶性肿瘤的时间趋势:年龄-时期-队列模型的应用。
Biomed Res Int. 2018 Mar 21;2018:5307459. doi: 10.1155/2018/5307459. eCollection 2018.

引用本文的文献

1
Different Patterns of the Relationship Between Gynecological Malignancy and Obesity Index: A Nationwide Retrospective Cohort Study in Korea.妇科恶性肿瘤与肥胖指数关系的不同模式:韩国一项全国性回顾性队列研究
J Korean Med Sci. 2025 Mar 24;40(11):e31. doi: 10.3346/jkms.2025.40.e31.
2
Surgical outcomes of single-port vs multi-port laparoscopic hysterectomy for endometrial cancer: A systematic review and meta-analysis.单孔与多孔腹腔镜子宫内膜癌根治术的手术效果:一项系统评价与荟萃分析
PLoS One. 2024 Dec 9;19(12):e0314997. doi: 10.1371/journal.pone.0314997. eCollection 2024.
3
Prognostic Role of CA-125 Elimination Rate Constant (KELIM) in Patients with Advanced Epithelial Ovarian Cancer Who Received PARP Inhibitors.

本文引用的文献

1
Bilateral salpingectomy to reduce the risk of ovarian/fallopian/peritoneal cancer in women at average risk: a position statement of the Korean Society of Obstetrics and Gynecology (KSOG).双侧输卵管切除术以降低平均风险女性患卵巢癌/输卵管癌/腹膜癌的风险:韩国妇产科协会(KSOG)的立场声明
Obstet Gynecol Sci. 2018 Sep;61(5):542-552. doi: 10.5468/ogs.2018.61.5.542. Epub 2018 Sep 7.
2
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2015.韩国癌症统计数据:2015 年发病率、死亡率、生存率和流行率。
Cancer Res Treat. 2018 Apr;50(2):303-316. doi: 10.4143/crt.2018.143. Epub 2018 Mar 21.
3
Prediction of Cancer Incidence and Mortality in Korea, 2018.
CA-125清除率常数(KELIM)在接受PARP抑制剂治疗的晚期上皮性卵巢癌患者中的预后作用
Cancers (Basel). 2024 Jun 26;16(13):2339. doi: 10.3390/cancers16132339.
4
Tissue Inhibitor of Metalloproteinase 3: Unravelling Its Biological Function and Significance in Oncology.组织金属蛋白酶抑制剂 3:揭示其在肿瘤学中的生物学功能和意义。
Int J Mol Sci. 2024 Mar 10;25(6):3191. doi: 10.3390/ijms25063191.
5
Correlation between estrogen receptor and programmed death ligand-1 in type I endometrial cancer.I型子宫内膜癌中雌激素受体与程序性死亡配体-1的相关性
Eur J Obstet Gynecol Reprod Biol X. 2024 Feb 20;21:100293. doi: 10.1016/j.eurox.2024.100293. eCollection 2024 Mar.
6
The new 2023 FIGO staging system for endometrial cancer: what is different from the previous 2009 FIGO staging system?新版 2023FIGO 子宫内膜癌分期系统:与旧版 2009FIGO 分期系统有何不同?
J Gynecol Oncol. 2024 Sep;35(5):e59. doi: 10.3802/jgo.2024.35.e59. Epub 2024 Jan 22.
7
Peritoneal mesometrial resection with lymphadenectomy following prior hysterectomy in intermediate/high-risk endometrial cancer: feasibility and safety.既往子宫切除术后中/高危子宫内膜癌行腹膜系膜切除术联合淋巴结切除术:可行性和安全性。
Arch Gynecol Obstet. 2024 Apr;309(4):1569-1574. doi: 10.1007/s00404-023-07275-3. Epub 2024 Jan 13.
8
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology consensus statement.韩国妇科肿瘤学会关于子宫体癌管理的实践指南:共识声明。
J Gynecol Oncol. 2024 Mar;35(2):e45. doi: 10.3802/jgo.2024.35.e45. Epub 2024 Jan 5.
9
Trends in the incidence and survival outcomes of endometrial cancer in Korea: a nationwide population-based cohort study.韩国子宫内膜癌发病率和生存结局的趋势:一项全国基于人群的队列研究。
J Gynecol Oncol. 2024 May;35(3):e32. doi: 10.3802/jgo.2024.35.e32. Epub 2023 Dec 19.
10
Incidence and survival of gynecologic cancer including cervical, uterine, ovarian, vaginal, vulvar cancer and gestational trophoblastic neoplasia in Korea, 1999-2019: Korea Central Cancer Registry.1999 - 2019年韩国妇科癌症(包括宫颈癌、子宫癌、卵巢癌、阴道癌、外阴癌和妊娠滋养细胞肿瘤)的发病率和生存率:韩国中央癌症登记处
Obstet Gynecol Sci. 2023 Nov;66(6):545-561. doi: 10.5468/ogs.23208. Epub 2023 Oct 27.
2018 年韩国癌症发病率与死亡率预测。
Cancer Res Treat. 2018 Apr;50(2):317-323. doi: 10.4143/crt.2018.142. Epub 2018 Mar 21.
4
Cancer statistics, 2018.癌症统计数据,2018 年。
CA Cancer J Clin. 2018 Jan;68(1):7-30. doi: 10.3322/caac.21442. Epub 2018 Jan 4.
5
Association of Mismatch Repair Mutation With Age at Cancer Onset in Lynch Syndrome: Implications for Stratified Surveillance Strategies.错配修复基因突变与林奇综合征发病年龄的关联:对分层监测策略的影响。
JAMA Oncol. 2017 Dec 1;3(12):1702-1706. doi: 10.1001/jamaoncol.2017.0619.
6
Nationwide cervical cancer screening in Korea: data from the National Health Insurance Service Cancer Screening Program and National Cancer Screening Program, 2009-2014.韩国全国范围内的宫颈癌筛查:来自国民健康保险服务癌症筛查项目和国家癌症筛查项目的数据,2009 - 2014年
J Gynecol Oncol. 2017 Sep;28(5):e63. doi: 10.3802/jgo.2017.28.e63. Epub 2017 May 26.
7
Position statements on genetic test for peritoneal, ovarian, and fallopian tubal cancers: Korean Society of Gynecologic Oncology (KSGO).关于腹膜癌、卵巢癌和输卵管癌基因检测的立场声明:韩国妇科肿瘤学会(KSGO)
J Gynecol Oncol. 2016 Jul;27(4):e36. doi: 10.3802/jgo.2016.27.e36. Epub 2016 Mar 30.
8
Uptake of risk-reducing salpingo-oophorectomy among female BRCA mutation carriers: experience at the National Cancer Center of Korea.韩国国家癌症中心女性 BRCA 突变携带者进行降低风险的输卵管卵巢切除术的情况:经验总结
J Cancer Res Clin Oncol. 2016 Jan;142(1):333-40. doi: 10.1007/s00432-015-2051-x. Epub 2015 Oct 5.
9
Incidence of cervical, endometrial, and ovarian cancer in Korea, 1999-2010.韩国 1999-2010 年宫颈癌、子宫内膜癌和卵巢癌的发病率。
J Gynecol Oncol. 2013 Oct;24(4):298-302. doi: 10.3802/jgo.2013.24.4.298. Epub 2013 Oct 2.
10
Identifying barriers to Papanicolaou smear screening in Korean women: Korean National Health and Nutrition Examination Survey 2005.识别韩国女性巴氏涂片筛查障碍:2005 年韩国国家健康和营养检查调查。
J Gynecol Oncol. 2010 Jun;21(2):81-6. doi: 10.3802/jgo.2010.21.2.81. Epub 2010 Jun 30.